SignatureFD
KURA icon

SignatureFD’s Kura Oncology KURA Stock Holding History

SignatureFD’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21.1K Sell
1,973
-56
-3% -$626 ﹤0.01% 2391
2026
Q2 		$22.3K Sell
2,029
-209
-9% -$1.97K ﹤0.01% 2293
2026
Q1 		$18.2K Buy
2,238
+1,147
+105% +$9.9K ﹤0.01% 2238
2025
Q4 		$11.3K Hold
1,091
– – ﹤0.01% 2376
2025
Q3 		$9.7K Sell
1,091
-993
-48% -$7.08K ﹤0.01% 2414
2025
Q2 		$12K Buy
2,084
+738
+55% +$4.52K ﹤0.01% 2277
2025
Q1 		$8.88K Sell
1,346
-783
-37% -$6.1K ﹤0.01% 2401
2024
Q4 		$18.5K Buy
2,129
+43
+2% +$619 ﹤0.01% 2095
2024
Q3 		$40.8K Sell
2,086
-3,192
-60% -$64.7K ﹤0.01% 1692
2024
Q2 		$109K Buy
5,278
+253
+5% +$5.2K ﹤0.01% 1122
2024
Q1 		$107K Sell
5,025
-13
-0.3% -$253 ﹤0.01% 1144
2023
Q4 		$72.4K Buy
5,038
+1,449
+40% +$14.2K ﹤0.01% 1285
2023
Q3 		$32.7K Buy
3,589
+172
+5% +$1.75K ﹤0.01% 1610
2023
Q2 		$36.2K Buy
3,417
+164
+5% +$1.94K ﹤0.01% 1594
2023
Q1 		$39.8K Buy
3,253
+322
+11% +$4.02K ﹤0.01% 1506
2022
Q4 		$36.4K Buy
2,931
+11
+0.4% +$160 ﹤0.01% 1508
2022
Q3 		$40K Buy
2,920
+33
+1% +$509 ﹤0.01% 1388
2022
Q2 		$53K Sell
2,887
-160
-5% -$2.3K ﹤0.01% 1258
2022
Q1 		$49K Buy
3,047
+122
+4% +$1.76K ﹤0.01% 1390
2021
Q4 		$41K Buy
2,925
+38
+1% +$616 ﹤0.01% 1425
2021
Q3 		$54K Hold
2,887
– – ﹤0.01% 1265
2021
Q2 		$60K Hold
2,887
– – ﹤0.01% 1192
2021
Q1 		$82K Hold
2,887
– – ﹤0.01% 963
2020
Q4 		$94K Buy
+2,887
New +$101K ﹤0.01% 813

Other funds holding KURA

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Xcel Wealth Management
Xcel Wealth Management Holly Hill, Florida $404M AUM 16.8% 1-Year Est. Return
Aaron Wealth Advisors
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Achmea Investment Management
Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return

SignatureFD's KURA Position: Q3 2026 in Review

SignatureFD reduced its Kura Oncology (KURA) stake by 2.8% in Q3 2026, selling an estimated $626 and leaving 1,973 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2391.

SignatureFD first reported a position in KURA in Q4 2020 and has held it in 24 quarters since. The position peaked at $109K in Q2 2024. 51 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • SignatureFD held 1,973 shares of Kura Oncology worth $21.1K as of Q3 2026.
  • SignatureFD sold 56 Kura Oncology shares in Q3 2026, an estimated $626.
  • Kura Oncology made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2391 holding.
  • SignatureFD first reported a position in Kura Oncology in Q4 2020 and has held it in 24 quarters since.
  • SignatureFD's Kura Oncology position peaked at $109K in Q2 2024.
  • 51 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.